“Descriptions of naturally occurring mystical experiences, and those generated by high level meditation practice, are strikingly similar to profound spiritual experiences occasioned by psychedelics” – Amanda Feilding
Why join the study?
In recent years, the scientific study of meditation and psychedelic drugs has seen remarkable developments, yet few attempts have been made at bridging these two domains of inquiry despite intriguing evidence of overlap between the phenomenology and neurophysiology of meditation practice and psychedelic states.
To close this gap, Amanda Feilding and the Beckley Foundation are leading a remote observational study in collaboration with Quantified Citizen, to explore the effects of regular microdosing (i.e., the practice of taking psychedelic substances – e.g. psilocybin or lysergic acid diethylamide; LSD – in small, sub-hallucinogenic doses) on meditation practice.
NB: you do not have to be microdosing to take part in the study
Visit the Quantified Citizen Microdosing and Meditation study page here.
Who can participate?
What does taking part in the study involve?
Involvement in this study will include completing an intake questionnaire (10 minutes), a set of assessments at the beginning of the study, after each month, and at the end of the study (for a total of 4 times, 20 minutes each). You will also be asked to complete a daily questionnaire that will take about 5 to 10 minutes each day.
Are psychedelics provided?
You will not be provided with psychedelic substances, or with instructions on where to obtain them or how to use them. If you are self-selecting into the microdosing group, you are already familiar with the practice and would be doing so regardless of being in this study.
You do not need to use psychedelics at any dose to take part in this study.
Are there any risks in taking part in this study or downloading the microdose.me app?
Only electronic anonymous data will be collected and stored. No data regarding your substance use will be stored on your phone.
The study is open to people who microdose and those who do not, and therefore downloading the app on your phone will not ‘label’ you as a user of psychedelics.
How can I take part?
Who is doing the study?
This study is being conducted as an international collaboration between Amanda Feilding and the Beckley Foundation, Marco Schlosser, Otto Simonson (researchers and expert meditators), Enzo Tagliazucchi (neuroscientist expert in psychedelic research), and Quantified Citizens. If you have any questions about this study, please contact firstname.lastname@example.org. Your email address will not be linked to your data in any way. If you have concerns about your privacy, please create an anonymous email address at protonmail.com. This service is free, anonymous, and encrypted.
Psilocybin for Depression
Type of publication